{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:24:59Z","timestamp":1790846699068,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Asahi Glass Foundation, Chulalongkorn University Centenary Academic Development Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11011-017-9982-7","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T04:47:44Z","timestamp":1488516464000},"page":"1003-1016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway"],"prefix":"10.1007","volume":"32","author":[{"given":"Buranee","family":"Kanchanatawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunee","family":"Sirivichayakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supaksorn","family":"Thika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Geffard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Noto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rada","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"issue":"3","key":"9982_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-011-2539-2","volume":"220","author":"KS Alexander","year":"2012","unstructured":"Alexander KS, Wu HQ, Schwarcz R, Bruno JP (2012) Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine. Psychopharmacology 220(3):627\u2013637","journal-title":"Psychopharmacology"},{"issue":"1","key":"9982_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/rep0000027","volume":"60","author":"D Amtmann","year":"2015","unstructured":"Amtmann D, Askew RL, Kim J, Chung H, Ehde DM, Bombardier CH, Kraft GH, Jones SM, Johnson KL (2015) Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis. Rehabil Psychol 60(1):81\u201390","journal-title":"Rehabil Psychol"},{"issue":"1","key":"9982_CR3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mehy.2010.08.029","volume":"76","author":"G Anderson","year":"2011","unstructured":"Anderson G (2011) Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination. Med Hypotheses 76(1):54\u201360","journal-title":"Med Hypotheses"},{"issue":"2","key":"9982_CR4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12035-013-8554-z","volume":"49","author":"G Anderson","year":"2014","unstructured":"Anderson G, Maes M (2014) Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol Neurobiol 49(2):771\u2013783","journal-title":"Mol Neurobiol"},{"issue":"6","key":"9982_CR5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.mehy.2012.02.023","volume":"78","author":"G Anderson","year":"2012","unstructured":"Anderson G, Maes M, Berk M (2012) Biological underpinnings of the commonalities in depression, somatization, and chronic fatigue syndrome. Med Hypotheses 78(6):752\u2013756","journal-title":"Med Hypotheses"},{"key":"9982_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pnpbp.2012.07.016","volume":"42","author":"G Anderson","year":"2013","unstructured":"Anderson G, Maes M, Berk M (2013) Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways. Prog Neuro-Psychopharmacol Biol Psychiatry 42:101\u2013114","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9982_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000291496","volume":"7","author":"NC Andreasen","year":"1989","unstructured":"Andreasen NC (1989) The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl 7:49\u201358","journal-title":"Br J Psychiatry Suppl"},{"issue":"7","key":"9982_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","volume":"39","author":"NC Andreasen","year":"1982","unstructured":"Andreasen NC, Olsen S (1982) Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 39(7):789\u2013794","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"9982_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881108089583","volume":"23","author":"S Barry","year":"2009","unstructured":"Barry S, Clarke G, Scully P, Dinan TG (2009) Kynurenine pathway in psychosis: evidence of increased tryptophan degradation. J Psychopharmacol 23(3):287\u2013294","journal-title":"J Psychopharmacol"},{"issue":"1","key":"9982_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","volume":"22","author":"S Bonaccorso","year":"2002","unstructured":"Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M (2002) Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22(1):86\u201390","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"9982_CR11","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.164.6.3283","volume":"164","author":"MC Bosco","year":"2000","unstructured":"Bosco MC, Rapisarda A, Massazza S, Melillo G, Young H, Varesio L (2000) The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and \u22121 beta in macrophages. J Immunol 164(6):3283\u20133291","journal-title":"J Immunol"},{"issue":"8","key":"9982_CR12","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.npp.1301005","volume":"31","author":"L Capuron","year":"2006","unstructured":"Capuron L, Welberg L, Heim C, Wagner D, Solomon L, Papanicolaou DA, Craddock RC, Miller AH, Reeves WC (2006) Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology 31(8):1777\u20131784","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"9982_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-1781(95)02712-6","volume":"58","author":"MJ Cuesta","year":"1995","unstructured":"Cuesta MJ, Peralta V (1995) Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Res 58(3):227\u2013235","journal-title":"Psychiatry Res"},{"key":"9982_CR14","doi-asserted-by":"publisher","unstructured":"Duleu S, Mangas A, Sevin F, Veyret B, Bessede A, Geffard M (2010) Circulating antibodies to IDO\/THO pathway metabolites in Alzheimer\u2019s disease. Int J Alzheimers Dis. doi: 10.4061\/2010\/501541","DOI":"10.4061\/2010\/501541"},{"issue":"11","key":"9982_CR15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4088\/JCP.v60n1105","volume":"60","author":"RA Emsley","year":"1999","unstructured":"Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein DJ (1999) Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. J Clin Psychiatry 60(11):747\u2013751","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"9982_CR16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00406-015-0629-6","volume":"266","author":"G Fervaha","year":"2016","unstructured":"Fervaha G, Agid O, Foussias G, Siddiqui I, Takeuchi H, Remington G (2016) Neurocognitive impairment in the deficit subtype of schizophrenia. Eur Arch Psychiatry Clin Neurosci 266(5):397\u2013407","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9982_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbi.2012.11.010","volume":"28","author":"SM Gibney","year":"2013","unstructured":"Gibney SM, McGuinness B, Prendergast C, Harkin A, Connor TJ (2013) Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun 28:170\u2013181","journal-title":"Brain Behav Immun"},{"key":"9982_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/IJTR.S2469","volume":"2","author":"RS Grant","year":"2009","unstructured":"Grant RS, Coggan SE, Smythe GA (2009) The physiological action of picolinic acid in the human brain. Int J Tryptophan Res 2:71\u201379","journal-title":"Int J Tryptophan Res"},{"issue":"1","key":"9982_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32(1):50\u201355","journal-title":"Br J Med Psychol"},{"key":"9982_CR20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"9982_CR21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstr\u00f6m KO (1991) The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstr\u00f6m tolerance questionnaire. Br J Addict 86(9):1119\u20131127","journal-title":"Br J Addict"},{"issue":"4","key":"9982_CR22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/PSY.0000000000000161","volume":"77","author":"KA Janssens","year":"2015","unstructured":"Janssens KA, Zijlema WL, Joustra ML, Rosmalen JG (2015) Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the LifeLines cohort study. Psychosom Med 77(4):449\u2013457","journal-title":"Psychosom Med"},{"key":"9982_CR23","doi-asserted-by":"publisher","unstructured":"Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Ormstad H, Anderson G, Maes M (2017a) Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid. Mol Neurobiol. doi: 10.1007\/s12035-017-0417-6","DOI":"10.1007\/s12035-017-0417-6"},{"key":"9982_CR24","doi-asserted-by":"crossref","unstructured":"Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M (2017b) Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift toward defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation. Mol Neurobiol (in press)","DOI":"10.1007\/s12035-017-0465-y"},{"issue":"2","key":"9982_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261\u2013276","journal-title":"Schizophr Bull"},{"key":"9982_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.psychres.2011.10.006","volume":"197","author":"JH Kim","year":"2012","unstructured":"Kim JH, Kim SY, Lee J, Oh KJ, Kim YB, Cho ZH (2012) Evaluation of the factor structure of symptoms in patients with schizophrenia. Psychiatry Res 197:285\u2013289","journal-title":"Psychiatry Res"},{"issue":"2","key":"9982_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","volume":"30","author":"B Kirkpatrick","year":"1989","unstructured":"Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30(2):119\u2013123","journal-title":"Psychiatry Res"},{"issue":"2","key":"9982_CR28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.58.2.165","volume":"58","author":"B Kirkpatrick","year":"2001","unstructured":"Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr (2001) A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58(2):165\u2013171","journal-title":"Arch Gen Psychiatry"},{"key":"9982_CR29","doi-asserted-by":"crossref","unstructured":"Kirschner M, Aleman A, Kaiser S (2016) Secondary negative symptoms - A review of mechanisms, assessment and treatment. Schizophr Res","DOI":"10.1016\/j.schres.2016.05.003"},{"key":"9982_CR30","unstructured":"Kittirathanapaiboon P, Khamwongpin M (2005) The Validity of the Mini International Neuropsychiatric Interview (M.I.N.I.) Thai Version: Suanprung Hospital, Department of Mental Health"},{"issue":"6","key":"9982_CR31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/pon.3710","volume":"24","author":"J Li","year":"2015","unstructured":"Li J, Yu L, Long Z, Li Y, Cao F (2015) Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue. Psychooncology 24(6):676\u2013682","journal-title":"Psychooncology"},{"key":"9982_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-642-76841-5_8","volume-title":"Negative Versus Positive Schizophrenia","author":"JA Lieberman","year":"1991","unstructured":"Lieberman JA, Jody D, Alvir MJ, Borenstein M, Mayerhoff DI, Geisler S, Szymanski S, Gonzales A, Bogerts B (1991) Negative symptoms in schizophrenia: relationship to positive symptoms and outcome. In: Marneros A, Andreasen N, Tsuang MT (eds) Negative Versus Positive Schizophrenia. Springer-Verlag, Berlin Heidelberg, pp 109\u2013125. doi: 10.1007\/978-3-642-76841-5_8"},{"key":"9982_CR33","first-page":"157","volume":"3","author":"CK Lim","year":"2010","unstructured":"Lim CK, Brew BJ, Sundaram G, Guillemin GJ (2010) Understanding the roles of the kynurenine pathway in multiple sclerosis progression. Int J Tryptophan Res 3:157\u2013167","journal-title":"Int J Tryptophan Res"},{"issue":"10","key":"9982_CR34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1024\/0040-5930.64.10.567","volume":"64","author":"A Linde","year":"2007","unstructured":"Linde A (2007) Chronic fatigue syndrome--a functional somatic syndrome. Ther Umsch 64(10):567\u2013574","journal-title":"Ther Umsch"},{"issue":"1","key":"9982_CR35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000284896","volume":"28","author":"JP Lindenmayer","year":"1995","unstructured":"Lindenmayer JP, Bernstein-Hyman R, Grochowski S, Bark N (1995) Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology 28(1):22\u201331","journal-title":"Psychopathology"},{"issue":"5","key":"9982_CR36","first-page":"564","volume":"30","author":"M Maes","year":"2009","unstructured":"Maes M (2009) \u201cFunctional\u201d or \u201cpsychosomatic\u201d symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression. Neuro Endocrinol Lett 30(5):564\u2013573","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"9982_CR37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.pnpbp.2010.06.023","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M (2011) An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):784\u2013794","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2\u20133","key":"9982_CR38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psychres.2011.09.029","volume":"196","author":"M Maes","year":"2012","unstructured":"Maes M, Rief W (2012) Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway. Psychiatry Res 196(2\u20133):243\u2013249","journal-title":"Psychiatry Res"},{"issue":"1","key":"9982_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-1781(90)90056-B","volume":"34","author":"M Maes","year":"1990","unstructured":"Maes M, Cosyns P, Maes L, D\u2019Hondt P, Schotte C (1990a) Clinical subtypes of unipolar depression: part I. A validation of the vital and nonvital clusters. Psychiatry Res 34(1):29\u201341","journal-title":"Psychiatry Res"},{"issue":"1","key":"9982_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0165-1781(90)90058-D","volume":"34","author":"M Maes","year":"1990","unstructured":"Maes M, Maes L, Schotte C, Vandewoude M, Martin M, D\u2019Hondt P, Blockx P, Scharp\u00e9 S, Cosyns P (1990b) Clinical subtypes of unipolar depression: Part III. Quantitative differences in various biological markers between the cluster-analytically generated nonvital and vital depression classes. Psychiatry Res 34(1):59\u201375","journal-title":"Psychiatry Res"},{"issue":"1\u20132","key":"9982_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000284842","volume":"27","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Cosyns P, Schotte C (1994) Evidence for the existence of major depression with and without anxiety features. Psychopathology 27(1\u20132):1\u201313","journal-title":"Psychopathology"},{"key":"9982_CR42","unstructured":"Maes M, Mihaylova I, Leunis JC (2006) Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett 27(5):615\u2013621"},{"issue":"6","key":"9982_CR43","first-page":"826","volume":"28","author":"M Maes","year":"2007","unstructured":"Maes M, Mihaylova I, Ruyter MD, Kubera M, Bosmans E (2007) The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. Neuro Endocrinol Lett 28(6):826\u2013831","journal-title":"Neuro Endocrinol Lett"},{"issue":"4","key":"9982_CR44","first-page":"470","volume":"30","author":"M Maes","year":"2009","unstructured":"Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009) Coenzyme Q10 deficiency in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME\/CFS due to cardiovascular disorder. Neuro Endocrinol Lett 30(4):470\u2013476","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"9982_CR45","first-page":"264","volume":"32","author":"M Maes","year":"2011","unstructured":"Maes M, Galecki P, Verkerk R, Rief W (2011a) Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity. Neuro Endocrinol Lett 32(3):264\u2013273","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"9982_CR46","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011b) The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):702\u2013721","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9982_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-642-76841-5_8","volume-title":"Negative Versus Positive Schizophrenia","author":"A Marneros","year":"1991","unstructured":"Marneros A, Deister A, Rohde A (1991) Long-term Monomorphism of negative and positive schizophrenic episodes. In: Marneros A, Andreasen N, Tsuang MT (eds) Negative Versus Positive Schizophrenia. Springer-Verlag, Berlin Heidelberg, pp 183\u2013196. doi: 10.1007\/978-3-642-76841-5_8"},{"key":"9982_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-642-76841-5_8","volume-title":"Negative Versus Positive Schizophrenia","author":"CS Mellor","year":"1991","unstructured":"Mellor CS (1991) Methodological problems in identifying and measuring first-rank symptoms of schizophrenia. In: Marneros A, Andreasen N, Tsuang MT (eds) Negative Versus Positive Schizophrenia. Springer-Verlag, Berlin Heidelberg, pp 71\u201378. doi: 10.1007\/978-3-642-76841-5_8"},{"issue":"8","key":"9982_CR49","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/1381612822666151215102420","volume":"22","author":"G Morris","year":"2016","unstructured":"Morris G, Carvalho AF, Anderson G, Galecki P, Maes M (2016) The many Neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of Neuro-immune disorders. Curr Pharm Des 22(8):963\u2013977","journal-title":"Curr Pharm Des"},{"issue":"6","key":"9982_CR50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/npp.2013.4","volume":"38","author":"SA Neale","year":"2013","unstructured":"Neale SA, Copeland CS, Uebele VN, Thomson FJ, Salt TE (2013) Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors. Neuropsychopharmacology 38(6):1060\u20131067","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"9982_CR51","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1590\/0001-3765201520140289","volume":"87","author":"GF Rio","year":"2015","unstructured":"Rio GF, Silva BV, Martinez ST, Pinto AC (2015) Anthranilic acids from isatin: an efficient, versatile and environmentally friendly method. An Acad Bras Cienc 87(3):1525\u20131529","journal-title":"An Acad Bras Cienc"},{"issue":"11","key":"9982_CR52","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.4088\/JCP.v64n1114","volume":"64","author":"M Ritsner","year":"2003","unstructured":"Ritsner M (2003) The attribution of somatization in schizophrenia patients: a naturalistic follow-up study. J Clin Psychiatry 64(11):1370\u20131378","journal-title":"J Clin Psychiatry"},{"key":"9982_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15622975.2016.1213881","volume":"30","author":"C Roomruangwong","year":"2016","unstructured":"Roomruangwong C, Kanchanatawan B, Carvalho AF, Sirivichayakul S, Duleu S, Geffard M, Maes M (2016a) Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway. World J Biol Psychiatry 30:1\u201310","journal-title":"World J Biol Psychiatry"},{"key":"9982_CR54","doi-asserted-by":"crossref","unstructured":"Roomruangwong C, Kanchanatawan B, Sirivichayakul S, Anderson G, Carvalho AF, Duleu S, Geffard M, Maes M (2016b) IgA\/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome. Mol Neurobiol 16","DOI":"10.2174\/1871527316666170407145533"},{"issue":"3","key":"9982_CR55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.yhbeh.2012.03.010","volume":"62","author":"A Salazar","year":"2012","unstructured":"Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O\u2019Connor JC (2012) Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav 62(3):202\u2013209","journal-title":"Horm Behav"},{"issue":"1","key":"9982_CR56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.schres.2013.07.009","volume":"150","author":"J Schaefer","year":"2013","unstructured":"Schaefer J, Giangrande E, Weinberger DR, Dickinson D (2013) The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res 150(1):42\u201350","journal-title":"Schizophr Res"},{"issue":"7","key":"9982_CR57","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4088\/JCP.v66n0705","volume":"66","author":"S Sevy","year":"2005","unstructured":"Sevy S, Rosenthal MH, Alvir J, Meyer S, Visweswaraiah H, Gunduz-Bruce H, Schooler NR (2005) Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications. J Clin Psychiatry 66(7):839\u2013843","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"9982_CR58","doi-asserted-by":"crossref","first-page":"E205","DOI":"10.1188\/09.ONF.E205-E214","volume":"36","author":"WK So","year":"2009","unstructured":"So WK, Marsh G, Ling WM, Leung FY, Lo JC, Yeung M, Li GK (2009) The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncol Nurs Forum 36(4):E205\u2013E214","journal-title":"Oncol Nurs Forum"},{"issue":"11","key":"9982_CR59","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/j.pain.0000000000000304","volume":"156","author":"B Stubbs","year":"2015","unstructured":"Stubbs B, Thompson T, Acaster S, Vancampfort D, Gaughran F, Correll CU (2015) Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies. Pain 156(11):2121\u20132131","journal-title":"Pain"},{"issue":"11","key":"9982_CR60","doi-asserted-by":"crossref","first-page":"e48553","DOI":"10.1371\/journal.pone.0048553","volume":"7","author":"O Taleb","year":"2012","unstructured":"Taleb O, Maammar M, Brumaru D, Bourguignon JJ, Schmitt M, Klein C, Kemmel V, Maitre M, Mensah-Nyagan AG (2012) Xanthurenic acid binds to neuronal G-protein-coupled receptors that secondarily activate cationic channels in the cell line NCB-20. PLoS One 7(11):e48553","journal-title":"PLoS One"},{"key":"9982_CR61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00092-5","volume":"18","author":"M Tyler","year":"1995","unstructured":"Tyler M (1995) Somatic symptoms in schizophrenia. Schizophr Res 18:87\u201388","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"9982_CR62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2005.09.002","volume":"82","author":"EJ Van den Oord","year":"2006","unstructured":"Van den Oord EJ, Rujescu D, Robles JR, Giegling I, Birrell C, Buksz\u00e1r J, Murrelle L, M\u00f6ller HJ, Middleton L, Muglia P (2006) Factor structure and external validity of the PANSS revisited. Schizophr Res 82(2\u20133):213\u2013223","journal-title":"Schizophr Res"},{"key":"9982_CR63","doi-asserted-by":"crossref","first-page":"425826","DOI":"10.1155\/2013\/425826","volume":"2013","author":"F Waters","year":"2013","unstructured":"Waters F, Naik N, Rock D (2013) Sleep, fatigue, and functional health in psychotic patients. Schizophr Res Treatment 2013:425826","journal-title":"Schizophr Res Treatment"},{"issue":"6","key":"9982_CR64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3999(01)00315-4","volume":"52","author":"O Zachrisson","year":"2002","unstructured":"Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG (2002) A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res 52(6):501\u2013509","journal-title":"J Psychosom Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-017-9982-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-017-9982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-017-9982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T07:57:39Z","timestamp":1568879859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-017-9982-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["9982"],"URL":"https:\/\/doi.org\/10.1007\/s11011-017-9982-7","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]}}}